Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof

US9771352B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Carsten Schmeck · Wuppertal, DE
• Michael Gerisch · Wuppertal, DE
• Nils Griebenow · Milford, US
• Peter Kolkhof · Wuppertal, DE
• Florian Kölling · Wuppertal, DE
• Anna ENGELEN · Essen, DE
• Axel Kretschmer · Wuppertal, DE
• Dieter Lang · Velbert, DE
• Klemens Lustig · Wuppertal, DE
• Thomas MONDRITZKI · Essen, DE
• Elisabeth Pook · Wuppertal, DE
• Hartmut Beck · Wuppertal, DE
• Frank Süβmeier · Birkenfeld, DE
• Sonja VOLLMER · Kleinmachnow, DE
• Pierre Wasnaire · Mülheim an der Ruhr, DE

Key dates

• Filing date: Nov 2, 2015
• Grant date: Sep 26, 2017
• Expiry date: Nov 27, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel 5-(hydroxyalkyl)-1-phenyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular and renal diseases.